ACVYFI
Live / Allowed — Notice of allowance issued (as of 17 Feb 2026)
What this means for you
Approved and waiting on proof of use. It will register unless the applicant drops it, and its 16 Jun 2025 filing date already counts against anyone who files later.
Record
- Serial number
- 99237066
- Mark type
- Stylized text
- Filed
- 16 Jun 2025
- Published for opposition
- 23 Dec 2025
- Attorney of record
- Andrea Christensen
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations for the treatment of autoimmune, cardiovascular, central nervous system, endocrine, gastrointestinal, genetic, infectious, inflammatory, kidney, liver, menopausal, metabolic, musculoskeletal, neurodegenerative, neurological, neuromuscular and viral diseases and disorders; Pharmaceutical preparations for the treatment of blood disorders, bone growth disorders, skin disorders, arthritis, cancer, cachexia, hypertension, pain, stroke, obesity and diabetes; Pharmaceuticals, namely, anti-infectives; Medicated dermatological preparations and substances; Smoking cessation preparations; Vaccines for human use
Owner
- Pfizer Inc., New York, NY, US
- Pfizer Inc., New York, NY, US
Prosecution history
- 17 Feb 2026 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 23 Dec 2025 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 23 Dec 2025 — PUBLISHED FOR OPPOSITION
- 17 Dec 2025 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 26 Nov 2025 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 04 Nov 2025 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 04 Nov 2025 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 04 Nov 2025 — TEAS RESPONSE TO OFFICE ACTION RECEIVED
- 28 Oct 2025 — NOTIFICATION OF NON-FINAL ACTION E-MAILED
- 28 Oct 2025 — NON-FINAL ACTION E-MAILED
- 28 Oct 2025 — NON-FINAL ACTION WRITTEN
- 22 Oct 2025 — ASSIGNED TO EXAMINER
- 17 Oct 2025 — TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
- 17 Oct 2025 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
- 17 Oct 2025 — ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED